A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects

NCT06932315 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Skeletal Muscle Relaxation

Interventions

DRUG: HRS-9190 for Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.